BLFS (STOCKS)
BioLife Solutions Inc.
$35.230000
+0.260000 (+0.74%)
Prev close: $34.970000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Roderick de Greef
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,874.91M
- Employees
- 159
- P/E (TTM)
- 36.16
- P/B (TTM)
- 4.07
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
8
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.04 | $0.03 | +0.0060 | +17.65% |
|
Mar 2026 (Q1)
|
$0.02 | $0.02 | -0.0004 | -1.96% |
|
Dec 2025 (Q4)
|
$0.22 | $-0.02 | +0.2421 | +1,095.48% |
|
Sep 2025 (Q3)
|
$0.01 | $-0.01 | +0.0219 | +184.03% |
Financial Statements
| Revenues | $102.82M |
| Benefits Costs and Expenses | $94.75M |
| Cost Of Revenue | $38.82M |
| Costs And Expenses | $45.56M |
| Gross Profit | $67.87M |
| Nonoperating Income/Loss | $5.09M |
| Operating Expenses | $45.56M |
| Research and Development | $8.25M |
| Other Operating Expenses | $37.31M |
| Operating Income/Loss | $2.98M |
| Income/Loss From Continuing Operations After Tax | $50.45M |
| Income/Loss From Continuing Operations Before Tax | $8.07M |
| Income/Loss From Discontinued Operations Net Of Tax | $7.54M |
| Income Tax Expense/Benefit | -$42.38M |
| Income Tax Expense/Benefit, Deferred | -$42.41M |
| Net Income/Loss | $57.98M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $57.98M |
| Net Income/Loss Available To Common Stockholders, Basic | $57.98M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.20 |
| Diluted Earnings Per Share | $1.18 |
| Basic Average Shares | 96,720,473 |
| Diluted Average Shares | 148,289,177 |
| Assets | $447.49M |
| Current Assets | $135.20M |
| Cash | $113.10M |
| Inventory | $35.59M |
| Noncurrent Assets | $312.30M |
| Fixed Assets | $15.24M |
| Intangible Assets | $3.65M |
| Other Non-current Assets | $293.41M |
| Liabilities | $27.49M |
| Current Liabilities | $13.95M |
| Accounts Payable | $2.48M |
| Other Current Liabilities | $11.47M |
| Noncurrent Liabilities | $13.54M |
| Long-term Debt | $0.00 |
| Equity | $420.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $420.00M |
| Liabilities And Equity | $447.49M |
| Net Cash Flow From Operating Activities | $16.88M |
| Net Cash Flow From Operating Activities, Continuing | $16.88M |
| Net Cash Flow From Investing Activities | -$8.24M |
| Net Cash Flow From Investing Activities, Continuing | -$8.24M |
| Net Cash Flow From Financing Activities | -$16.54M |
| Net Cash Flow From Financing Activities, Continuing | -$16.54M |
| Net Cash Flow | -$7.91M |
| Net Cash Flow, Continuing | -$7.91M |
| Comprehensive Income/Loss | $57.70M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $57.70M |
| Other Comprehensive Income/Loss | $62.29M |